Sacubitril CAS 149709-62-6 98% Purity API Intermediate for Heart Failure Research
TDS
149709-62-6
Reagent Grade
99%
qingdao
//
10mg, 25mg, 50mg, 100mg, 1g
Yes
2026-10-26
Medetomidine,Medetomidine hydrochloride,D-Lysergic Acid Methyl Ester,SR17018,Fluralaner,GS-441524
-
Product Description
-
Seller Information
-
DescriptionECHEMI Editorial ReferenceAHU377 and angiotensin IIAT1 receptor antagonist valsartan at a molar ratio of 1: 1 compose LCZ696. LCZ696 was a dual inhibitor of angiotensin II (AT2) receptor and enkephalinase (Neprilysin) receptor. And with its better antihypertensive efficacy than standard antihypertensive drugs, it is a new drug for the treatment of heart failure. AHU377 is a prodrug that converts the active form of the enzyme cleavage LBQ657 ethyl ester. So far its efficacy and safety in milestone phase III surpas.
Sacubitril is a member of biphenyls.|Sacubitril is a prodrug neprilysin inhibitor used in combination with valsartan to reduce the risk of cardiovascular events in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction. It was approved by the FDA after being given the status of priority review for on July 7, 2015. Sacubitril's active metabolite, LBQ657 inhibits neprilysin, a neutral endopeptidase that would typically cleave natiuretic peptides such as atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and c-type natriuretic peptide (CNP). ANP and BNP are released under atrial and ventricle stress, which activate downstream receptors leading to vasodilation, natriuresis and diuresis. Under normal conditions, neprilysin breaks down other vasodilating peptides and also vasoconstrictors such as angiotensin I and II, endothelin-1 and peptide amyloid beta-protein. Inhibition of neprilysin therefore leads to reduced breakdown and increased concentration of endogenous natriuretic peptides in addition to increased levels of vasoconstricting hormones such as angiotensin II.|Sacubitril is a neprilysn (NEP) inhibitor prodrug with natriuretic activity. Upon administration, sacubitril is metabolized by esterases to its active metabolite, sacubitrilat, which inhibits NEP, a neutral endopeptidase that cleaves natriuretic peptides such as atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), and c-type natriuretic peptide (CNP), as well as certain vasoconstricting peptides including as angiotensin I and II, and endothelin-1. Additionally, sacubitrilat may inhibit NEP-mediated catabolism of certain peptide-based agents, thereby improving their in vivo stability and increasing tumor cell exposure.
ChEBI: Sacubitril is a member of biphenyls.Research & Reference NoteSacubitril CAS 149709-62-6 98% Purity API Intermediate for Heart Failure Research is listed on ECHEMI for industrial / laboratory sourcing. This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Authoritative sourcesDisclaimer: This listing is for industrial and laboratory research use. Product information on ECHEMI is provided for sourcing and specification reference. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.
Reviewed by ECHEMI Scientific Review - Platform editorial review for research chemicals
Certificates-
TDS
Basic Info-
Product Name:
AHU-377
Other Name:4-(((2R,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-Methyl-5-oxopentan-2-yl)aMino)-4-oxobutanoic acid;AHU-377;4-(((2S,4R)-1-([1,1'-biphenyl]-4-yl)-5-ethoxy-4-Methyl-5-oxopentan-2-yl)aMino)-4-oxobutanoic acid;(2R,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic acid ethyl ester;AHU-377,149709-62-6;AHU-37;AHU377; AHU 377; SACUBITRIL;LCZ696(valsartan + sacubitril) impurity 4
CAS No.:149709-62-6
Molecular Formula:C24H29NO5
InChIKeys:PYNXFZCZUAOOQC-VNLCLAKNNA-N
Molecular Weight:411.49
Exact Mass:411.49
EC Number:1592732-453-0
UNII:17ERJ0MKGI
DSSTox ID:DTXSID20164370
NCI Thesaurus Code:C152281
Color/Form:colorless
ATC Code:C09DX04
Categories:
Characteristics-
PSA:
92.7
XLogP3:3.96
Density:1.151±0.06 g/cm3(Predicted)
Boiling Point:656.9±55.0 °C(Predicted)
Flash Point:351.1±31.5 °C
Refractive Index:1.549
PKA:4.72±0.10(Predicted)
Critical Temperature & Pressure:Sealed in dry,Store in freezer, under -20°C
Hazard IdentificationClassification of the substance or mixture
no data available
GHS label elements, including precautionary statements
Pictogram(s) no data available Signal word no data available
Hazard statement(s) no data available
Precautionary statement(s) Prevention no data available
Response no data available
Storage no data available
Disposal no data available
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Medetomidine,Medetomidine hydrochloride,D-Lysergic Acid Methyl Ester,SR17018,Fluralaner,GS-441524
-
Location:
RONGSHENG BEIYUANDAJIE 9, LICHENG DISTRICT,JINAN, SHANDONG CHINA
-
Payment Terms:
TT against copy of documents,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
7 days
-
Total Annual Revenue:
$1 million-$2.5 million
-
Total Employees:
11-50
-
Year of Establishment:
2022
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
More from this Seller
-
-
-
Tavapadon CAS 1643489-24-0 98% Purity Dopamine D1 Receptor Partial Agonist API Intermediate for Parkinson's Disease Research fk
Reagent Grade / 99%
$100-130/G FOB
-
-
-
-
Purpureaside B 98% Purity Natural Phenylethanoid Glycoside Reference Standard CAS 104777-69-7 HPLC Grade Small Molecule Compound
Research Grade / 98%
$60-68/G FOB
-
-
-
-
Digitoxigenin 97% Purity Natural Cardiac Glycoside Aglycone Reference Standard CAS 143-62-4 HPLC Grade Small Molecule Compound
Research Grade / 97%
$54-58/G FOB
-
-
-
-
3-(Methylsulfonyl)benzaldehyde 98% Purity Aromatic Aldehyde Building Block CAS 43114-43-8 Pharmaceutical Intermediate
Research Grade / 98%
$65-68/G FOB
-
-
-
-
L-tert-Leucinamide Hydrochloride CAS 75158-12-2 Chiral Amino Acid Derivative for lab Synthesis use
Reagent Grade / 99%
$100-130/G FOB
-
-
-
-
Uzarigenin 3-O-beta-D-digitaloside 98% Purity Natural Cardiac Glycoside Reference Standard CAS 61217-80-9 HPLC Grade
Research Grade / 98%
$48-55/G FOB
-